Pais et al. coupled the estrogen inhibitor 17β-estradiol and the estrogen activator Tamoxifen to PTA-Gd to prepare breast cancer estrogen receptor (ER)-based MRI molecules nanoprobes. The gene discussed is ESR1; the disease is breast carcinoma.